seri
pyrimidinon
deriv
bear
differ
substitu
posit
synthes
use
highli
regioselect
lithiationesubstitut
protocol
effect
structur
variat
posit
antivir
activ
cell
cultur
evalu
although
deriv
found
activ
variou
viru
strain
effect
close
toxic
threshold
efficaci
interferon
mediat
antivir
respons
virusinfect
host
well
establish
one
import
approach
adopt
antivir
therapi
use
interferon
induc
agent
capabl
stimul
interferon
product
rang
virus
bacteri
cell
wall
synthet
compound
biopolym
along
small
group
lowmolecularweight
compound
fig
compound
report
induc
interferon
includ
n
ndioctadecyln
n
bi
propanediamin
n
n
bi
fluorenon
tiloron
diethylamino
ethyl
amino
nucleobas
deriv
adenin
although
compound
pyrimidinon
fig
report
induc
interferon
rodent
cat
administ
oral
intraperiton
observ
exhibit
toxicitylimit
crystal
deposit
renal
papilla
rat
upon
chronic
administr
subsequ
studi
demonstr
analogu
abmp
possess
toxic
exhibit
enhanc
interferoninduc
antivir
potenc
activ
biolog
evalu
initi
lead
candid
secondgener
pyrimidinon
seri
pyrimidinon
reveal
intrigu
spectrum
immunomodulatori
activ
may
relat
antivir
antitumour
activ
present
studi
highli
regioselect
efficaci
protocol
prepar
elabor
pyrimidinon
requir
elucid
structureeact
relationship
sar
pyrimidinon
seri
report
addit
rather
elabor
antivir
assay
seri
new
compound
along
examin
cytotox
carri
compound
pyrimidinon
readili
synthes
condens
bketoest
ethylacetoacet
guanidin
carbon
ethanoletoluen
mixtur
scheme
obtain
yield
follow
report
procedur
order
append
differ
substitu
posit
compound
synthesi
scheme
commenc
protect
nh
group
compound
tertbutyloxycarbonyl
boc
group
use
et
n
base
thf
c
obtain
desir
compound
yield
scheme
metallation
alkyl
sequenc
use
synthesi
deriv
compound
order
fulli
exploit
synthesi
potenti
procedur
reaction
lithium
deriv
compound
sever
electrophil
investig
scheme
compound
exhibit
satisfactori
characterist
data
vide
experiment
anion
intermedi
gener
situ
treat
compound
nbuli
equiv
anhydr
thf
c
atmospher
dri
nitrogen
ga
treatment
appropri
electrophil
ethyl
bromid
npropyl
bromid
nbutyl
bromid
equiv
tabl
c
led
substitut
nucleophil
vinylog
methyl
thu
format
correspond
onalkyl
product
observ
subsequ
quench
satur
aqueou
solut
nh
cl
c
afford
deriv
scheme
deriv
treat
trifluoroacet
acid
methylen
chlorid
vv
mixtur
room
temperatur
without
purif
obtain
compound
good
yield
tabl
entri
similarli
compound
subject
abovement
metal
reaction
follow
quench
benzen
obtain
compound
subsequ
deprotect
produc
desir
compound
yield
tabl
likewis
reaction
anion
intermedi
aceton
follow
deprotect
correspond
produc
good
yield
compound
achiev
diversif
compound
reaction
anion
intermedi
perform
aldehyd
thu
reaction
compound
nbuli
follow
reaction
subsequ
deprotect
correspond
intermedi
tfa
produc
good
yield
compound
tabl
entri
likewis
reaction
anion
speci
subsequ
deprotect
tfa
produc
good
yield
compound
tabl
entri
evid
format
product
suggest
situ
elimin
water
correspond
carbinol
acid
catalyz
condit
use
deprotect
reaction
substitut
analogu
compound
name
compound
obtain
good
excel
yield
tabl
entri
reaction
respect
compound
bromin
acet
acid
room
temperatur
scheme
antivir
assay
base
inhibit
virusinduc
cytopath
crfk
felin
corona
viru
fipv
felin
herp
viru
hel
herp
simplex
viru
hsv
ko
g
vaccinia
viru
vesicular
stomat
viru
vsv
tk
ko
acv
r
vero
sindbi
viru
coxsacki
punta
toro
viru
hela
vsv
coxsacki
viru
respiratori
syncyti
viru
mdck
influenza
b
viru
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
cell
cultur
inhibitori
viru
viru
dose
infect
cell
cultur
along
vari
concentr
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
tabl
see
support
inform
show
activ
cytotox
data
compound
variou
viru
strain
antivsv
result
observ
hela
cell
cultur
tabl
entri
could
observ
hel
cell
cultur
tabl
entri
compound
r
ch
c
h
ch
ch
show
activ
ec
mm
davi
strain
ec
mm
cytomegaloviru
hel
cell
cultur
activ
close
toxic
threshold
tabl
entri
similarli
compound
also
exhibit
activ
varicellazost
viru
vzv
strain
tk
vzv
oka
ec
mm
tk
vzv
ec
mm
hel
cell
cultur
close
toxic
threshold
tabl
entri
crfk
cell
cultur
compound
present
activ
felin
herp
viru
concentr
well
cellular
toxic
threshold
tabl
entri
howev
none
compound
present
activ
vaccinia
viru
vsv
hel
cell
cultur
tabl
entri
compound
possess
respect
nbutyl
npentyl
npentyl
substitu
posit
present
pronounc
antivir
activ
ec
mm
close
toxic
threshold
tabl
entri
furthermor
antivsv
activ
observ
hel
cell
cultur
toxic
compound
also
lower
vero
cell
cultur
none
compound
show
activ
parainfluenza
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
tabl
entri
mdck
cell
cultur
compound
found
inact
influenza
viru
tabl
entri
new
seri
pyrimidinon
deriv
bear
differ
substitu
posit
synthes
correspond
pyrimidinon
synthet
use
manner
obtain
deriv
evalu
antivir
activ
seri
cell
cultur
although
deriv
found
activ
variou
viru
strain
differ
cell
cultur
effect
close
toxic
threshold
liquid
reagent
driedpurifi
use
recommend
dri
agent
andor
distil
molecular
siev
h
nmr
mhz
c
nmr
mhz
spectra
record
dmsod
cdcl
multinuclear
jeol
instrument
chemic
shift
report
part
per
million
rel
intern
tetramethylsilan
tm
h
nmr
cdcl
c
nmr
mass
spectra
record
indian
institut
integr
medicin
csir
jammu
india
electron
impact
ev
bruker
dalton
esquir
spectromet
element
analysi
perform
flash
ea
thermoelectron
corpor
analyz
depart
chemistri
guru
nanak
dev
univers
amritsar
india
result
present
percentag
ir
record
ftir
shimadzu
fouriertransform
spectrophotomet
rang
cm
use
kbr
melt
point
determin
open
capillari
correct
monitor
progress
reaction
comparison
purpos
thin
layer
chromatographi
perform
precoat
aluminium
sheet
merck
mm
use
appropri
solvent
system
chromatogram
visual
uv
light
column
chromatographi
silica
gel
mesh
employ
eluent
ethyl
acet
hexan
mixtur
tabl
synthesi
deriv
pyrimidinon
pyrimidinon
compound
r
yield
anal
calcd
c
h
n
c
h
n
found
c
h
n
ms
mz
suspens
compound
mmol
dri
thf
ml
blanket
dri
n
n
nbuli
mmol
ad
drop
wise
c
addit
reaction
mixtur
stir
room
temperatur
h
quench
c
electrophil
mmol
dissolv
dri
thf
ml
reaction
stir
room
temperatur
h
complet
reaction
cold
satur
aqueou
solut
nh
cl
ml
introduc
c
reaction
content
extract
ethyl
acet
ml
treat
brine
wash
water
ml
dri
anhydr
na
concentr
reduc
pressur
obtain
crude
compound
compound
treat
tfa
dcm
room
temperatur
h
complet
reaction
solvent
remov
reduc
pressur
reaction
residu
neutral
base
reaction
content
extract
ethyl
acet
ml
dri
anhydr
na
concentr
reduc
pressur
requir
compound
purifi
column
chromatographi
use
silica
gelg
mesh
mixtur
ethyl
acetatehexan
eluent
characterist
data
compound
follow
brown
solid
anal
calcd
c
h
n
c
h
n
found
c
h
n
ms
mz
anal
calcd
c
h
n
c
h
n
found
c
h
n
ms
mz
gener
procedur
synthesi
substitut
deriv
suspens
compound
equiv
glacial
acet
acid
ml
bromin
equiv
ad
drop
wise
reaction
mixtur
allow
stir
room
temperatur
h
complet
reaction
tlc
solvent
remov
reduc
pressur
solid
residu
wash
water
obtain
requir
compound
characterist
data
compound
follow
parainfluenza
influenza
viru
subtyp
influenza
viru
b
sindbi
punta
toro
viru
antivir
assay
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
cell
vero
human
cervix
carcinoma
epitheli
cell
hela
madinedarbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
cmv
vzv
respect
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
format
